IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes
IMPROVE-DiCE 是一项分为两部分、开放标签的 2a 期试验，旨在评估 Ninerafaxstat 在心血管代谢综合征患者中的安全性和有效性。
期刊:Circulation
影响因子:38.6
doi:10.1161/CIRCULATIONAHA.125.074041
Hundertmark, Moritz J; Birkhoelzer, Sarah M; Portwood, Clara; Siu, Adrienne G; Matthews, Violet; Lewis, Andrew J; Grist, James; Mózes, Ferenc; Henry, John A; Patel, Jai; Chamberlin, Paul; Sarwar, Rizwan; Yavari, Arash; Dehbi, Hakim-Moulay; Rao, Prashant; Shi, Xu; Zheng, Shuning; Robbins, Jeremy M; Gerszten, Robert E; Frenneaux, Michael P; Valkovič, Ladislav; Miller, Jack J J J; Neubauer, Stefan; Tyler, Damian J; Rider, Oliver J
